We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
脑蛋白水解物注射液对老年帕金森患者的疗效分析.
- Authors
刘文萍; 李静; 彭颜晖; 刘丽丹; 沈静怡; 徐佳骏
- Abstract
Objective: To investigate the efficacy and safety of brain protein hydrolysate injection in the treatment of elderly patients with parkinson. Methods: 120 patients with parkinson were selected and randomly divided into two groups. The control group (57 cases) was treated by routine treatment, while the observation group (63 cases) was given brain protein hydrolysate injection on the basis of routine treatment. The UPDRS scores, SF-36 scores and adverse reactions during treatment were observed and recorded. Results: Before treatment, the UPDRS and SF-36 scores of both groups had no significant difference (P>0.05). After treatment, the UPDRS scores of both groups were significantly decreased, and the UPDRS score of observation group was lower than that of the control group(P<0.05). The social function, emotional function, mental health score of observation group were higher than those of the control group(P<0.05). During treatment, 1 cases of dizziness, 1 cases of nausea were found in the control group. The adverse reaction rate was 3.5%. 2 cases of insomnia,1 cases of fatigue,1 cases of dizziness and 1 cases of nausea were found in the observation group. The adverse reaction rate was 7.9%. There was no statistical difference in the incidence of adverse reactions between two groups (P>0.05). Conclusion: Brain protein hydrolysate injection had significant effect on the Parkinson. It could improve the patients' thinking ability, mental health and quality of life with high safety.
- Publication
Progress in Modern Biomedicine, 2017, Vol 17, Issue 27, p5312
- ISSN
1673-6273
- Publication type
Article
- DOI
10.13241/j.cnki.pmb.2017.27.028